- call +1-201-465-4211
- email sales@mrinsights.biz
Morphine is a pain medication of the opiate variety which is found naturally in a number of plants and animals. It acts directly on the central nervous system (CNS) to decrease the feeling of pain. It can be taken for both acute pain and chronic pain. It is frequently used for pain from myocardial infarction and during labour. It can be given by mouth, by injection into a muscle, by injecting under the skin, intravenously, into the space around the spinal cord, or rectally. Maximum effect is around 20 minutes when given intravenously and 60 minutes when given by mouth, while duration of effect is 3–7 hours. Long-acting formulations also exist.
Scope of the Report:
This report focuses on the Medical Morphine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The increasing prevalence of arthritis and cancer in geriatric patients is projected to impact the morphine market globally positively. The global medical morphine market is consolidated in nature owing to the dominance of few companies in manufacturing and processing. Morphine production is regulated by stringent regulation policies passed by several countries which would hamper its manufacturing. North America dominated the global medical morphine market and is expected to maintain its position in global market attributed to its increasing consumption in the U.S.
The worldwide market for Medical Morphine is expected to grow at a CAGR of roughly 2.3% over the next five years, will reach 12300 million US$ in 2023, from 11000 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Pfizer
Sun Pharmaceutical Industries
Taj Pharmaceuticals Limited
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Injectables
Market Segment by Applications, can be divided into
Cancer
Arthritis
There are 15 Chapters to deeply display the global Medical Morphine market.
Chapter 1, to describe Medical Morphine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Medical Morphine, with sales, revenue, and price of Medical Morphine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Medical Morphine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Medical Morphine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Medical Morphine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Medical Morphine Introduction
1.2 Market Analysis by Type
1.2.1 Oral
1.2.2 Injectables
1.3 Market Analysis by Applications
1.3.1 Cancer
1.3.2 Arthritis
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Mallinckrodt Pharmaceuticals
2.1.1 Business Overview
2.1.2 Medical Morphine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Mallinckrodt Pharmaceuticals Medical Morphine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Alcaliber
2.2.1 Business Overview
2.2.2 Medical Morphine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Alcaliber Medical Morphine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Purdue Pharma
2.3.1 Business Overview
2.3.2 Medical Morphine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Purdue Pharma Medical Morphine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Medical Morphine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Medical Morphine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sun Pharmaceutical Industries
2.5.1 Business Overview
2.5.2 Medical Morphine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sun Pharmaceutical Industries Medical Morphine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Taj Pharmaceuticals Limited
2.6.1 Business Overview
2.6.2 Medical Morphine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Taj Pharmaceuticals Limited Medical Morphine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Medical Morphine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Medical Morphine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Medical Morphine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Medical Morphine Manufacturer Market Share in 2017
3.3.2 Top 6 Medical Morphine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Medical Morphine Market Analysis by Regions
4.1 Global Medical Morphine Sales, Revenue and Market Share by Regions
4.1.1 Global Medical Morphine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Medical Morphine Revenue and Market Share by Regions (2013-2018)
4.2 North America Medical Morphine Sales and Growth Rate (2013-2018)
4.3 Europe Medical Morphine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Medical Morphine Sales and Growth Rate (2013-2018)
4.5 South America Medical Morphine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Medical Morphine Sales and Growth Rate (2013-2018)
5 North America Medical Morphine by Countries
5.1 North America Medical Morphine Sales, Revenue and Market Share by Countries
5.1.1 North America Medical Morphine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Medical Morphine Revenue and Market Share by Countries (2013-2018)
5.2 United States Medical Morphine Sales and Growth Rate (2013-2018)
5.3 Canada Medical Morphine Sales and Growth Rate (2013-2018)
5.4 Mexico Medical Morphine Sales and Growth Rate (2013-2018)
6 Europe Medical Morphine by Countries
6.1 Europe Medical Morphine Sales, Revenue and Market Share by Countries
6.1.1 Europe Medical Morphine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Medical Morphine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Medical Morphine Sales and Growth Rate (2013-2018)
6.3 UK Medical Morphine Sales and Growth Rate (2013-2018)
6.4 France Medical Morphine Sales and Growth Rate (2013-2018)
6.5 Russia Medical Morphine Sales and Growth Rate (2013-2018)
6.6 Italy Medical Morphine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Medical Morphine by Countries
7.1 Asia-Pacific Medical Morphine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Medical Morphine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Medical Morphine Revenue and Market Share by Countries (2013-2018)
7.2 China Medical Morphine Sales and Growth Rate (2013-2018)
7.3 Japan Medical Morphine Sales and Growth Rate (2013-2018)
7.4 Korea Medical Morphine Sales and Growth Rate (2013-2018)
7.5 India Medical Morphine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Medical Morphine Sales and Growth Rate (2013-2018)
8 South America Medical Morphine by Countries
8.1 South America Medical Morphine Sales, Revenue and Market Share by Countries
8.1.1 South America Medical Morphine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Medical Morphine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Medical Morphine Sales and Growth Rate (2013-2018)
8.3 Argentina Medical Morphine Sales and Growth Rate (2013-2018)
8.4 Colombia Medical Morphine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Medical Morphine by Countries
9.1 Middle East and Africa Medical Morphine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Medical Morphine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Medical Morphine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Medical Morphine Sales and Growth Rate (2013-2018)
9.3 UAE Medical Morphine Sales and Growth Rate (2013-2018)
9.4 Egypt Medical Morphine Sales and Growth Rate (2013-2018)
9.5 Nigeria Medical Morphine Sales and Growth Rate (2013-2018)
9.6 South Africa Medical Morphine Sales and Growth Rate (2013-2018)
10 Global Medical Morphine Market Segment by Type
10.1 Global Medical Morphine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Medical Morphine Sales and Market Share by Type (2013-2018)
10.1.2 Global Medical Morphine Revenue and Market Share by Type (2013-2018)
10.2 Oral Sales Growth and Price
10.2.1 Global Oral Sales Growth (2013-2018)
10.2.2 Global Oral Price (2013-2018)
10.3 Injectables Sales Growth and Price
10.3.1 Global Injectables Sales Growth (2013-2018)
10.3.2 Global Injectables Price (2013-2018)
11 Global Medical Morphine Market Segment by Application
11.1 Global Medical Morphine Sales Market Share by Application (2013-2018)
11.2 Cancer Sales Growth (2013-2018)
11.3 Arthritis Sales Growth (2013-2018)
12 Medical Morphine Market Forecast (2018-2023)
12.1 Global Medical Morphine Sales, Revenue and Growth Rate (2018-2023)
12.2 Medical Morphine Market Forecast by Regions (2018-2023)
12.2.1 North America Medical Morphine Market Forecast (2018-2023)
12.2.2 Europe Medical Morphine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Medical Morphine Market Forecast (2018-2023)
12.2.4 South America Medical Morphine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Medical Morphine Market Forecast (2018-2023)
12.3 Medical Morphine Market Forecast by Type (2018-2023)
12.3.1 Global Medical Morphine Sales Forecast by Type (2018-2023)
12.3.2 Global Medical Morphine Market Share Forecast by Type (2018-2023)
12.4 Medical Morphine Market Forecast by Application (2018-2023)
12.4.1 Global Medical Morphine Sales Forecast by Application (2018-2023)
12.4.2 Global Medical Morphine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Medical Morphine Picture
Table Product Specifications of Medical Morphine
Figure Global Sales Market Share of Medical Morphine by Types in 2017
Table Me
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
